On August 5, MicuRx Pharmaceuticals, an antimicrobial drug development company announced the completion of a Series D financing round worth nearly 300 million yuan.
The round was led by Huagai Capital, and joined by Sinopharm-CICC and Zero2IPO Ventures.
The reproductive specialist chain Haoyunbang (Good pregnancy help) focused on infertility has completed a new round of financing, led by Zero2IPO Ventures.
Dashixiong (Master Bear) has raised tens of millions of yuanin Series A financing round, led by Zero2IPO Ventures and joined by existing investor Lanhai Zhongli Capital. Sanjiangyuan Capital served as the financial advisor for the round of financing.